2019
DOI: 10.1016/j.euroneuro.2018.11.419
|View full text |Cite
|
Sign up to set email alerts
|

A PPAR-alpha agonist gemfibrozil ameliorates cognitive and memory impairments in a sporadic Alzheimer's disease rat model

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
2
0

Year Published

2020
2020
2020
2020

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 5 publications
0
2
0
Order By: Relevance
“…MWM test was performed to rats for evaluating spatial learning (59). There was a decrease in latency to find the platform underwater in all groups during the training phase.…”
Section: Discussionmentioning
confidence: 99%
“…MWM test was performed to rats for evaluating spatial learning (59). There was a decrease in latency to find the platform underwater in all groups during the training phase.…”
Section: Discussionmentioning
confidence: 99%
“…This disease is expressed by the presence of β-amyloid plaque, intracellular neurofibrillary tangles (NFTs), synaptic deterioration and neuronal death. Although various drugs (rivastigmine, galantamine, donepezil, memantine, tacrine) are used for the treatment of AD, their success in completely eliminating symptoms is low (Colovic, Krstić, Lazarević-Pašti, Bondžić, & Vasić, 2013;Ulep, Saraon, & McLea, 2018;Yildiz, Cam, Keles, Hazar-Yavuz, & Kabasakal, 2019).…”
mentioning
confidence: 99%